EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P Wheatley iD

Molecular Oncology · 2026-03 · 20 (3) · 727-752

DOI: 10.1002/1878-0261.70141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 12.10.2025. Verfasst von Hana Abdelkabir und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, University of Nottingham, UK. Hauptthemen laut MEDLINE: Survivin, Aurora Kinase A, Mitosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The spindle assembly checkpoint (SAC) delays the metaphase‐to‐anaphase transition. Aurora kinase A (AURKA) inactivation has been shown to cause premature exit from mitosis in the presence of an unsatisfied SAC. We report for the first time that centromeric AURKA interacts with survivin during prometaphase. Notably, depleting or inhibiting AURKA activity at this stage causes mislocalisation of the CPC and BubR1, which compromises the SAC and can lead to mitotic slippage. Furthermore, we show that AURKA binds directly to the BIR domain of survivin at a position distinct from AURKB and indirectly to it via its C terminus. We find the interaction peaks during prometaphase but persists into late mitosis. Importantly, we demonstrate that cells with high levels of survivin are particularly vulnerable to mitotic slippage induced by the AURKA inhibitor, MLN8237/ Alisertib. Alisertib enables both normal and transformed cells with high levels of survivin to activate the APC/C prematurely, as observed by the destruction of cyclin B and securin. Thus, a high expression of survivin can alter cell fate decisions at mitosis and lead to genetic instability, a key hallmark in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SurvivinAurora Kinase AMitosisHumansHeLa CellsPyrimidinesProtein BindingProtein Serine-Threonine KinasesAzepinesAurora Kinase B

Stichwörter der Autor:innen

aurora kinasechromosomal passenger complex (CPC)mitosismitotic slippagespindle assembly checkpoint (SAC)survivin

Substanzen

SurvivinAurora Kinase ABIRC5 protein, humanMLN 8237AURKA protein, humanPyrimidinesProtein Serine-Threonine KinasesAzepinesAurora Kinase B

Autor:innen und Institutionen

  • School of Life Sciences, University of Nottingham, UK.

ORCID-Profile: Sally P Wheatley

Zitieren

APA

Abdelkabir, H., Arachchige, S. W., & Wheatley, S. P. (2026). Survivin and Aurora Kinase A control cell fate decisions during mitosis. Molecular Oncology, 20(3), 727-752. https://doi.org/10.1002/1878-0261.70141

Vancouver

Abdelkabir H, Arachchige SW, Wheatley SP. Survivin and Aurora Kinase A control cell fate decisions during mitosis. Molecular Oncology. 2026;20(3):727-752. doi:10.1002/1878-0261.70141

BibTeX
@article{Abdelkabir2026,
  author = {Abdelkabir, Hana and Arachchige, Shalitha Wickrama and Wheatley, Sally P},
  title = {Survivin and Aurora Kinase A control cell fate decisions during mitosis},
  journal = {Molecular Oncology},
  year = {2026},
  volume = {20},
  number = {3},
  pages = {727--752},
  doi = {10.1002/1878-0261.70141}
}
Kostenlos starten →